These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2970411

  • 1. Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent.
    Giugliano D, Cozzolino D, Salvatore T, Torella R, D'Onofrio F.
    Diabetes; 1988 Sep; 37(9):1265-70. PubMed ID: 2970411
    [Abstract] [Full Text] [Related]

  • 2. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D, Cozzolino D, Salvatore T, Torella R, Franchimont P, D'Onofrio F, Lefebvre PJ.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [Abstract] [Full Text] [Related]

  • 3. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D, Cozzolino D, Salvatore T, Ceriello A, Giunta R, Torella R, D'Onofrio F.
    Diabete Metab; 1987 Aug; 13(6):618-24. PubMed ID: 2896134
    [Abstract] [Full Text] [Related]

  • 4. Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
    Giugliano D, Cozzolino D, Salvatore T, Ceriello A, Torella R, Franchimont P, Lefebvre PJ, D'Onofrio F.
    Metabolism; 1992 Feb; 41(2):184-90. PubMed ID: 1736041
    [Abstract] [Full Text] [Related]

  • 5. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
    Cozzolino D, Sessa G, Salvatore T, Sasso FC, Giugliano D, Lefebvre PJ, Torella R.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):713-8. PubMed ID: 8636293
    [Abstract] [Full Text] [Related]

  • 6. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man.
    Paolisso G, Giugliano D, Scheen AJ, Franchimont P, D'Onofrio F, Lefèbvre PJ.
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):161-9. PubMed ID: 2885994
    [Abstract] [Full Text] [Related]

  • 7. Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP.
    Giugliano D, Cozzolino D, Ceriello A, Salvatore T, Paolisso G, Torella R.
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E361-6. PubMed ID: 2551176
    [Abstract] [Full Text] [Related]

  • 8. Beta-endorphin-induced hyperglycemia in rabbits: effects of a glucose or arginine challenge.
    Schleicher RL, Chawla RK, Coan PA, Martino-Saltzman D, Collins DC.
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E255-9. PubMed ID: 2950769
    [Abstract] [Full Text] [Related]

  • 9. Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity.
    Giugliano D, Cozzolino D, Torella R, Lefebvre PJ, Franchimont P, D'Onofrio F.
    Acta Endocrinol (Copenh); 1991 Feb; 124(2):159-65. PubMed ID: 2003375
    [Abstract] [Full Text] [Related]

  • 10. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
    el-Tayeb KM, Vranic M, Brubaker PL, Lickley HL.
    Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
    [Abstract] [Full Text] [Related]

  • 11. Beta-endorphin inhibits insulin secretion from isolated pancreatic islets.
    Schleicher RL.
    Endocrinology; 1989 Mar; 124(3):1254-8. PubMed ID: 2521821
    [Abstract] [Full Text] [Related]

  • 12. Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus.
    Giugliano D, Ceriello A, Salvatore T, Paolisso G, D'Onofrio F, Lefèbvre P.
    J Clin Endocrinol Metab; 1987 May; 64(5):944-8. PubMed ID: 2951394
    [Abstract] [Full Text] [Related]

  • 13. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D, Salvatore T, Cozzolino D, Ceriello A, Torella R, D'Onofrio F.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity to beta-endorphin as a cause of human obesity.
    Giugliano D, Salvatore T, Cozzolino D, Ceriello A, Torella R, D'Onofrio F.
    Metabolism; 1987 Oct; 36(10):974-8. PubMed ID: 2958673
    [Abstract] [Full Text] [Related]

  • 15. Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.
    Ahrén B.
    Int J Pancreatol; 1989 Sep; 5(2):165-78. PubMed ID: 2574736
    [Abstract] [Full Text] [Related]

  • 16. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT, Revers RR, Kolterman OG, Rubenstein AH, Olefsky JM.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.